168 related articles for article (PubMed ID: 22660369)
1. Do botulinum toxins have a role in the management of neuropathic pain?: a focused review.
Francisco GE; Tan H; Green M
Am J Phys Med Rehabil; 2012 Oct; 91(10):899-909. PubMed ID: 22660369
[TBL] [Abstract][Full Text] [Related]
2. Botulinum Toxin for Neuropathic Pain: A Review of the Literature.
Oh HM; Chung ME
Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242
[TBL] [Abstract][Full Text] [Related]
3. Botulinum Toxin Treatment of Neuropathic Pain.
Mittal SO; Safarpour D; Jabbari B
Semin Neurol; 2016 Feb; 36(1):73-83. PubMed ID: 26866499
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Toxin for the Treatment of Neuropathic Pain.
Park J; Park HJ
Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28837075
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
Luvisetto S; Gazerani P; Cianchetti C; Pavone F
Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
Sandrini G; De Icco R; Tassorelli C; Smania N; Tamburin S
J Headache Pain; 2017 Dec; 18(1):38. PubMed ID: 28324318
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous and perineural botulinum toxin type a for neuropathic pain: a descriptive review.
Fabregat G; De Andrés J; Villanueva-Pérez VL; Asensio-Samper JM
Clin J Pain; 2013 Nov; 29(11):1006-12. PubMed ID: 23370086
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Guided Nerve Block with Botulinum Toxin Type A for Intractable Neuropathic Pain.
Moon YE; Choi JH; Park HJ; Park JH; Kim JH
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26761032
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-Rehabilitation.
Intiso D; Basciani M; Santamato A; Intiso M; Di Rienzo F
Toxins (Basel); 2015 Jun; 7(7):2454-80. PubMed ID: 26134256
[TBL] [Abstract][Full Text] [Related]
10. A focused review on the use of botulinum toxins for neuropathic pain.
Argoff CE
Clin J Pain; 2002; 18(6 Suppl):S177-81. PubMed ID: 12569966
[TBL] [Abstract][Full Text] [Related]
11. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain.
Bagues A; Hu J; Alshanqiti I; Chung MK
Pharmacol Ther; 2024 Jul; 259():108668. PubMed ID: 38782121
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin for neuropathic pain and spasticity: an overview.
Brown EA; Schütz SG; Simpson DM
Pain Manag; 2014 Mar; 4(2):129-51. PubMed ID: 24641437
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin and painful peripheral neuropathies: what should be expected?].
Ranoux D
Rev Neurol (Paris); 2011 Jan; 167(1):46-50. PubMed ID: 21194720
[TBL] [Abstract][Full Text] [Related]
14. A novel therapeutic with two SNAP-25 inactivating proteases shows long-lasting anti-hyperalgesic activity in a rat model of neuropathic pain.
Wang J; Casals-Diaz L; Zurawski T; Meng J; Moriarty O; Nealon J; Edupuganti OP; Dolly O
Neuropharmacology; 2017 May; 118():223-232. PubMed ID: 28347837
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Toxin Type A-A Modulator of Spinal Neuron-Glia Interactions under Neuropathic Pain Conditions.
Rojewska E; Piotrowska A; Popiolek-Barczyk K; Mika J
Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29614835
[TBL] [Abstract][Full Text] [Related]
16. Use of Botulinum Toxin in Orofacial Clinical Practice.
Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure.
Dressler D; Bigalke H; Benecke R
J Neurol; 2003 Aug; 250(8):967-9. PubMed ID: 12928917
[TBL] [Abstract][Full Text] [Related]
18. Topical Review: Potential Use of Botulinum Toxin in the Management of Painful Posttraumatic Trigeminal Neuropathy.
Moreau N; Dieb W; Descroix V; Svensson P; Ernberg M; Boucher Y
J Oral Facial Pain Headache; 2017 Winter; 31(1):7-18. PubMed ID: 28118416
[TBL] [Abstract][Full Text] [Related]
19. Multidimensional Effectiveness of Botulinum Toxin in Neuropathic Pain: A Systematic Review of Randomized Clinical Trials.
Lippi L; de Sire A; Folli A; D'Abrosca F; Grana E; Baricich A; Carda S; Invernizzi M
Toxins (Basel); 2022 Apr; 14(5):. PubMed ID: 35622555
[TBL] [Abstract][Full Text] [Related]
20. [Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia].
Halb L; Amann BJ; Bornemann-Cimenti H
Nervenarzt; 2017 Apr; 88(4):408-414. PubMed ID: 27924350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
